Global Influenza Vaccines Report Thumbnail

Global Influenza Vaccines Market by Type (Trivalent Flu Vaccines, Quadrivalent Flu Vaccines), By Application (Adults, Pediatrics) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

  • Report ID: PH-38877
  • Author: Up Market Research
  • Rating: 4.7
  • Total Reviews: 79
  • No. Of Pages: 243
  • Format:
  • Pub. Date: 2021-04-04
  • Share:

Up Market Research published a new report titled “Influenza Vaccines Market research report which is segmented by Types (Trivalent Flu Vaccines, Quadrivalent Flu Vaccines), By Applications (Adults, Pediatrics), By Players/Companies AstraZeneca, CSL, GlaxoSmithKline, Sanofi, Altimmune, BionVax, FluGen, FOLIA BIOTECH, Genentech, Green Cross, Medicago, Moderna Therapeutics, Novavax, Shijiazhuang Yiling Pharmaceutical, SK Chemicals, UNM Pharma, Vaccitech, Vaxart, Vaxine Pty, Visterra”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.


Report Scope

Report AttributesReport Details
Report TitleInfluenza Vaccines Market Research Report
By TypeTrivalent Flu Vaccines, Quadrivalent Flu Vaccines
By ApplicationAdults, Pediatrics
By CompaniesAstraZeneca, CSL, GlaxoSmithKline, Sanofi, Altimmune, BionVax, FluGen, FOLIA BIOTECH, Genentech, Green Cross, Medicago, Moderna Therapeutics, Novavax, Shijiazhuang Yiling Pharmaceutical, SK Chemicals, UNM Pharma, Vaccitech, Vaxart, Vaxine Pty, Visterra
Regions CoveredNorth America, Europe, APAC, Latin America, MEA
Base Year2020
Historical Year2018 to 2019 (Data from 2010 can be provided as per availability)
Forecast Year2028
Number of Pages243
Number of Tables & Figures171
Customization AvailableYes, the report can be customized as per your need.

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.


Global Influenza Vaccines Industry Outlook

Global Influenza Vaccines Market Report Segments:

The market is segmented by Type Trivalent Flu Vaccines, Quadrivalent Flu Vaccines and By Application Adults, Pediatrics.


Some of the companies that are profiled in this report are:

  1. AstraZeneca
  2. CSL
  3. GlaxoSmithKline
  4. Sanofi
  5. Altimmune
  6. BionVax
  7. FluGen
  8. FOLIA BIOTECH
  9. Genentech
  10. Green Cross
  11. Medicago
  12. Moderna Therapeutics
  13. Novavax
  14. Shijiazhuang Yiling Pharmaceutical
  15. SK Chemicals
  16. UNM Pharma
  17. Vaccitech
  18. Vaxart
  19. Vaxine Pty
  20. Visterra

Influenza Vaccines Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.


Key Benefits for Industry Participants & Stakeholders:

  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Influenza Vaccines Market

Overview of the regional outlook of the Influenza Vaccines Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.


Influenza Vaccines Market Overview

Highlights of The Influenza Vaccines Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of Influenza Vaccines Market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2028.
  5. Developments and trends in the market.
  6. By Type:

                1. Trivalent Flu Vaccines

                2. Quadrivalent Flu Vaccines

       7. By Application:

                1. Adults

                2. Pediatrics

  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Influenza Vaccines Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.


How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Influenza Vaccines Market Statistics

Reasons to Purchase the Influenza Vaccines Market Report:

  • The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
  • Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
  • Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
  • The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
  • Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Influenza Vaccines Market Overview
   4.1 Introduction 
      4.1.1 Market Taxonomy 
      4.1.2 Market Definition 
      4.1.3 Macro-Economic Factors Impacting the Market Growth 
   4.2 Influenza Vaccines Market Dynamics 
      4.2.1 Market Drivers 
      4.2.2 Market Restraints 
      4.2.3 Market Opportunity 
   4.3 Influenza Vaccines Market - Supply Chain Analysis 
      4.3.1 List of Key Suppliers 
      4.3.2 List of Key Distributors 
      4.3.3 List of Key Consumers 
   4.4 Key Forces Shaping the Influenza Vaccines Market 
      4.4.1 Bargaining Power of Suppliers 
      4.4.2 Bargaining Power of Buyers 
      4.4.3 Threat of Substitution 
      4.4.4 Threat of New Entrants 
      4.4.5 Competitive Rivalry 
   4.5 Global Influenza Vaccines Market Size & Forecast, 2018-2028 
      4.5.1 Influenza Vaccines Market Size and Y-o-Y Growth 
      4.5.2 Influenza Vaccines Market Absolute $ Opportunity 


Chapter 5 Global Influenza Vaccines Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2 Influenza Vaccines Market Size Forecast by Type
      5.2.1 Trivalent Flu Vaccines
      5.2.2 Quadrivalent Flu Vaccines
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global Influenza Vaccines Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2 Influenza Vaccines Market Size Forecast by Applications
      6.2.1 Adults
      6.2.2 Pediatrics
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Influenza Vaccines Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Influenza Vaccines Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America Influenza Vaccines Analysis and Forecast
   9.1 Introduction
   9.2 North America Influenza Vaccines Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America Influenza Vaccines Market Size Forecast by Type
      9.6.1 Trivalent Flu Vaccines
      9.6.2 Quadrivalent Flu Vaccines
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America Influenza Vaccines Market Size Forecast by Applications
      9.10.1 Adults
      9.10.2 Pediatrics
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe Influenza Vaccines Analysis and Forecast
   10.1 Introduction
   10.2 Europe Influenza Vaccines Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe Influenza Vaccines Market Size Forecast by Type
      10.6.1 Trivalent Flu Vaccines
      10.6.2 Quadrivalent Flu Vaccines
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe Influenza Vaccines Market Size Forecast by Applications
      10.10.1 Adults
      10.10.2 Pediatrics
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific Influenza Vaccines Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific Influenza Vaccines Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific Influenza Vaccines Market Size Forecast by Type
      11.6.1 Trivalent Flu Vaccines
      11.6.2 Quadrivalent Flu Vaccines
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific Influenza Vaccines Market Size Forecast by Applications
      11.10.1 Adults
      11.10.2 Pediatrics
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America Influenza Vaccines Analysis and Forecast
   12.1 Introduction
   12.2 Latin America Influenza Vaccines Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America Influenza Vaccines Market Size Forecast by Type
      12.6.1 Trivalent Flu Vaccines
      12.6.2 Quadrivalent Flu Vaccines
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America Influenza Vaccines Market Size Forecast by Applications
      12.10.1 Adults
      12.10.2 Pediatrics
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA) Influenza Vaccines Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA) Influenza Vaccines Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA) Influenza Vaccines Market Size Forecast by Type
      13.6.1 Trivalent Flu Vaccines
      13.6.2 Quadrivalent Flu Vaccines
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA) Influenza Vaccines Market Size Forecast by Applications
      13.10.1 Adults
      13.10.2 Pediatrics
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Influenza Vaccines Market: Competitive Dashboard
   14.2 Global Influenza Vaccines Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 AstraZeneca
      14.3.2 CSL
      14.3.3 GlaxoSmithKline
      14.3.4 Sanofi
      14.3.5 Altimmune
      14.3.6 BionVax
      14.3.7 FluGen
      14.3.8 FOLIA BIOTECH
      14.3.9 Genentech
      14.3.10 Green Cross
      14.3.11 Medicago
      14.3.12 Moderna Therapeutics
      14.3.13 Novavax
      14.3.14 Shijiazhuang Yiling Pharmaceutical
      14.3.15 SK Chemicals
      14.3.16 UNM Pharma
      14.3.17 Vaccitech
      14.3.18 Vaxart
      14.3.19 Vaxine Pty
      14.3.20 Visterra
Segments Covered in the Report
The global Influenza Vaccines market has been segmented based on

By Types
  • Trivalent Flu Vaccines
  • Quadrivalent Flu Vaccines
By Applications
  • Adults
  • Pediatrics
Regions
  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa
Key Players
  • AstraZeneca
  • CSL
  • GlaxoSmithKline
  • Sanofi
  • Altimmune
  • BionVax
  • FluGen
  • FOLIA BIOTECH
  • Genentech
  • Green Cross
  • Medicago
  • Moderna Therapeutics
  • Novavax
  • Shijiazhuang Yiling Pharmaceutical
  • SK Chemicals
  • UNM Pharma
  • Vaccitech
  • Vaxart
  • Vaxine Pty
  • Visterra

Buy Report